Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shockwave therapy could ease stubborn neck pain

NCT ID NCT07660523

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

This pilot study tests whether focused shockwave therapy can reduce pain and improve function in people with chronic neck and shoulder muscle pain. Sixty adults will be randomly assigned to receive either three weekly shockwave sessions or a home exercise program. Researchers will measure pain, disability, and muscle changes using ultrasound.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
focused extracorporeal shockwave therapy
What this could lead to
If it works, this could provide a noninvasive treatment option for chronic neck and shoulder muscle pain.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply widely. The therapy may not prove more effective than simple home exercises.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults older than 20 years. * Clinical diagnosis of nonspecific neck and shoulder pain primarily arising from muscles and soft tissues in the upper trapezius or levator scapulae region, as determined by a physical medicine and rehabilitation physician. * Neck and shoulder pain lasting for at least 3 months. * Neck Disability Index score greater than 5. * No use of analgesic medication or muscle relaxants within the previous month. * No injection therapy, physical therapy, or other treatment for neck and shoulder pain within the previous month. * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * Neck or shoulder pain caused by a neurologic disorder, including cervical radiculopathy. * Clinical or imaging diagnosis of cervical degenerative joint disease. * History of a rheumatic disease, including rheumatoid arthritis or systemic lupus erythematosus. * History of head or neck trauma. * History of cervical spine surgery. * History of whiplash injury. * Pregnancy. * Current or previous malignancy considered clinically relevant to shockwave therapy. * Bleeding disorder. * Current use of anticoagulant medication, including warfarin. * Acute inflammation or infection at the treatment site. * Implanted cardiac pacemaker or implantable cardioverter-defibrillator. * Any other condition judged by the study physician to make participation or focused shockwave therapy inappropriate or unsafe.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myofascial pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CiShan hospital, Ministry of Health and Welfare

    RECRUITING

    Kaohsiung City, 80230, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.